Brachytherapy
Volume 8, Issue 3 , Pages 273-275 , July 2009

Counterpoint: The dose rate argument—Does size matter after all?

  • Alexandra J. Stewart

      Affiliations

    • Department of Radiotherapy, Royal Surrey County Hospital, Guildford, Surrey, United Kingdom
    • ,
  • Phillip M. Devlin

      Affiliations

    • Department of Radiation Oncology, Dana Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, Dana Farber Cancer Institute/Brigham and Women's Hospital, 75 Francis Street L2, Boston, MA 02115. Tel.: +1-617-732-6331; fax: +1-617-278-6988.
    • ,
  • Subhakar Mutyala

      Affiliations

    • Department of Radiation Oncology, Montefiore Medical Center, Bronx, NY

References 

  1. International Commission on Radiation Units and Measurements . Dose and volume specifications for reporting intracavitary therapy in gynecology (report 38). Bethesda, MD: International Commission on Radiation Units and Measurements; 1985;
  2. Nag S, Orton C, Young D, et al. The American Brachytherapy Society survey of brachytherapy practice for carcinoma of the cervix in the United States. Gynecol Oncol. 1999;73:111–118
  3. Pearce A, Craighead P, Kay I, et al. Brachytherapy for carcinoma of the cervix: A Canadian survey of practice patterns in a changing era. Radiother Oncol. 2009;91:194–196
  4. Teshima T, Inoue T, Ikeda H, et al. High dose rate and low dose rate intracavitary therapy for carcinoma of the uterine cervix. Final results of Osaka University Hospital. Cancer. 1993;72:2409–2414
  5. Patel FD, Sharma SC, Negi PS, et al. Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: A clinical trial. Int J Radiat Oncol Biol Phys. 1993;28:335–341
  6. Lertsanguansinchai P, Lertbutsayanukul C, Shotelersuk K, et al. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma. Int J Radiat Oncol Biol Phys. 2004;59:1424–1431
  7. Hareyama M, Sakata K, Oouchi A, et al. High dose rate versus low dose rate intracavitary therapy for carcinoma of the uterine cervix. Cancer. 2002;94:117–124
  8. Shrivastava S, Dinshaw K, Mahantshetty U, et al. Comparing low-dose-rate and high-dose-rate intracavitary brachytherapy in carcinoma cervix: Results from a randomised controlled study. Int J Radiat Oncol Biol Phys. 2006;66:S42
  9. Stewart AJ, Viswanathan AN. Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer. Cancer. 2006;107:908–915
  10. Petereit DG, Sarkaria JN, Potter DM, et al. High dose rate versus low dose rate brachytherapy in the treatment of cervical cancer: Analysis of tumor recurrence—the University of Wisconsin experience. Int J Radiat Oncol Biol Phys. 1999;45:1267–1274
  11. Chao KSC, Williamson JF, Grigsby PW, et al. Uterosacral space in involvement in locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1998;40:397–403
  12. Kucera H, Potter R, Knocke TH, et al. High dose versus low dose rate brachytherapy in definitive radiotherapy of cervical cancer. Wien Klin Wochenschr. 2001;113:58–62
  13. Hoskin PJ, Rembowska A. Dosimetry rules for brachytherapy using high dose rate remote afterloading implants. Clin Oncol. 1998;10:226–230
  14. Decker WE, Erickson B, Albano K, et al. Comparison of traditional low dose rate to optimized and nonoptimized high dose rate tandem and ovoid dosimetry. Int J Radiat Oncol Biol Phys. 2001;50:561–567
  15. Noyes WR, Peters NE, Thomadsen BR, et al. Impact of “optimized” treatment planning for tandem and ring, tandem and ovoid's, using high dose rate brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 1995;31:79–86
  16. Mai J, Erickson B, Rownd J, et al. Comparison of four different dose specification methods for high dose rate intracavitary radiation for treatment of cervical cancer. Int J Radiat Oncol Biol Phys. 2001;51:1131–1141
  17. Lee SW, Suh CO, Chung EJ, et al. Dose optimization of fractionated external radiation and high dose rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma. Int J Radiat Oncol Biol Phys. 2002;52:1338–1344
  18. Foroudi F, Bull CA, Gebski V. Radiation therapy for cervix carcinoma: Benefits of individualized dosimetry. Clin Oncol. 2002;14:43–49
  19. Dale RG, Jones B. The clinical radiobiology of brachytherapy. Br J Radiol. 1998;71:465–483
  20. Rogers CL, Freel JH, Speiser BL. Pulsed low dose rate brachytherapy for uterine cervix carcinoma. Int J Radiat Oncol Biol Phys. 1999;43:95–100
  21. Swift PS, Purser P, Roberts LW, et al. Pulsed low dose rate brachytherapy for pelvic malignancies. Int J Radiat Oncol Biol Phys. 1997;37:811–817
  22. Stewart AJ, Jones B. Radiobiological concepts in brachytherapy. In:  Devlin P editors. Brachytherapy: techniques and applications. 1st ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2006;
  23. Haie-Meder C, Potter R, Van Limbergen E, et al. Recommendations from the Gynaecological (GYN) GEC ESTRO Working Group: Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74:235–245
  24. Potter R, Dimopoulos J, Georg P, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol. 2007;83:148–155
  25. Stitt JA, Fowler JF, Thomadsen BR, et al. High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological consideration. Int J Radiat Oncol Biol Phys. 1992;24:335–348
  26. Hama Y, Uematsu M, Nagata I, et al. Carcinoma of the uterine cervix: twice versus once-weekly high dose rate brachytherapy. Radiology. 2001;219:207–212
  27. Fertil B, Malaise EP. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: Analysis of 101 published cell curves. Int J Radiat Oncol Biol Phys. 1985;11:1699–1707
  28. Sorbe B, Straumits A, Karlsson L. Intravaginal high-dose-rate brachytherapy for stage I endometrial cancer: A randomized study of two dose-per-fraction levels. Int J Radiat Oncol Biol Phys. 2005;62:1385–1389
  29. Houdek PV, Schwade JG, Abitbol AA, et al. Optimization of high dose-rate cervix brachytherapy. Part I: Dose distribution. Int J Radiat Oncol Biol Phys. 1991;21:1621
  30. Demanes DJ, Rodriguez RR, Bendre DD, et al. High dose rate transperineal interstitial brachytherapy for cervical cancer: High pelvic control and low complication rates. Int J Radiat Oncol Biol Phys. 1999;45:105–112
  31. Dimopoulous JC, Kirisits C, Petric P, et al. The Vienna applicator for combines intracavitary and interstitial brachytherapy of cervical cancer: Clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys. 2006;66:83–90
  32. Sood BM, Gorla G, Gupta S, et al. Two fractions of high dose rate brachytherapy in the management of cervix cancer: Clinical experience with and without chemotherapy. Int J Radiat Oncol Biol Phys. 2002;53:702–706
  33. Nag S, Dally M, de la Torre M, et al. Recommendations for implementation of high dose rate 192 Ir brachytherapy in developing countries by the advisory group of International Atomic Energy Agency. Radiother Oncol. 2002;64:297–308
  34. Bastin K, Buchler D, Stitt J, et al. Resource utilization: High dose rate versus low dose rate brachytherapy for gynecologic cancer. Am J Clin Oncol. 1993;16:256–263
  35. Pinilla J. Cost minimization analysis of high-dose-rate versus low-dose-rate brachytherapy in endometrial cancer. Gynecology Tumor Group. Int J Radiat Oncol Biol Phys. 1998;42:87–90
  36. Corn BW, Galvin JM, Soffen EM, et al. Positional stability of sources during low-dose-rate brachytherapy for cervical carcinoma. Int J Radiat Oncol Biol Phys. 1993;26:513–518
  37. Pham HT, Chen Y, Rouby E. Changes in high-dose-rate tandem and ovoid applicator positions during treatment in an unfixed brachytherapy system. Radiology. 1998;206:525–531
  38. Souttar HS. Radium and cancer. London, UK: William Heinemann; 1934;
  39. Potter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC ESTRO Working Group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78:67–77

PII: S1538-4721(09)00228-1

doi: 10.1016/j.brachy.2009.06.003

Brachytherapy
Volume 8, Issue 3 , Pages 273-275 , July 2009

Article Tools